ALB and acute kidney injury: These findings emphasize the importance of optimizing treatment protocols: early initiation of terlipressin infusion at a higher dose (4 mg/day) with optimized albumin usage could decrease morbidity and mortality associated with HRS-AKI and minimize the adverse effects associated with terlipressin.